clinical trial · NCT07441200
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
NS Pharma, Inc.·phase2·not yet recruiting·n = 135
Pulmonary Arterial HypertensionNS-863 Low DoseNS-863 High DoseNS-863 Placebo
brief summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Arterial Hypertension (PAH)
started
Jul 1, 2026
primary completion
Aug 1, 2028
completion
Nov 1, 2028
last updated
Feb 27, 2026
official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol